Pointing to an almost one per cent growth in three-month revenues which totalled $367 million, CEO Audley Reid said though ...

The majority of Teva's business lies in generic and off-patent branded drugs and faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...

With more than 440 drugs currently on a shortage list, Prime Time looks at what is causing the issue and how it's affecting ...

The biopharmaceutical industry faces a future full of risks and rewards. But what role will 3PL suppliers play?

Will include cold storage, dry storage, temperature-controlled facilities, and specialised spaces for pharmaceutical and ...

Drug distribution company Cencora has been preparing for the DSCSA for the past decade, Matt Sample, SVP of manufacturer and ...